A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 25
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : OHE
Long Form : overt HE
No. Year Title Co-occurring Abbreviation
2020 Management of hepatic encephalopathy in Germany: a survey among physicians. CHE, GPs, MHE
2020 Meta-analysis of magnetic resonance spectroscopy in the diagnosis of hepatic encephalopathy. CENTRAL, CI, CINAHL, HE, LILACS, MHE, MRS, NHE
2019 L-Ornithine L-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses. HE, LOLA, MHE, RCTs, TIPSS
2019 Predictive Power of Liver Maximum Function Capacity Test in Transjugular Intrahepatic Portosystemic Shunt Patients: A Pilot Study. HE, LFAC, LiMAx, TIPSS
2019 Prognostic Implications of Minimal/Covert Hepatic Encephalopathy: Large-scale Validation Cohort Studies. HE, MHE/CHE, QOL
2018 Clinical outcomes and hospital costs of hepatic encephalopathy: an analysis of "real life" data from Marche Region. HE, RW
2018 Efficacy of l-Ornithine l-Aspartate for the Treatment of Hepatic Encephalopathy and Hyperammonemia in Cirrhosis: Systematic Review and Meta-Analysis of Randomized Controlled Trials. CI, HE, LOLA, MD, MHE, RR
2017 Natural history of covert hepatic encephalopathy: An observational study of 366 cirrhotic patients. CHE
2017 Serum 25-hydroxyvitamin D deficiency and hepatic encephalopathy in chronic liver disease. CLD, HE, MELD
10  2017 Severity-specific alterations in CBF, OEF and CMRO2 in cirrhotic patients with hepatic encephalopathy. CBF, CHE, HE, OEF
11  2016 Contemporary Understanding and Management of Overt and Covert Hepatic Encephalopathy. CHE, HE
12  2016 Cost-effectiveness analysis of rifaximin-alpha administration for the reduction of episodes of overt hepatic encephalopathy in recurrence compared with standard treatment in France. HE, QALY
13  2016 Hepatic encephalopathy in patients with non-cirrhotic portal hypertension: Description, prevalence and risk factors. CHE, HE, INCPH, NCPH, PVT
14  2016 Probiotics are helpful in hepatic encephalopathy: a meta-analysis of randomized trials. CI, HE, MHE, OR, OR
15  2015 Advances in cirrhosis: Optimizing the management of hepatic encephalopathy. CHE, HE
16  2015 FOUR score, a reliable score for assessing overt hepatic encephalopathy in cirrhotic patients. FOUR, GCS, HE, WH
17  2015 Validation of EncephalApp, Smartphone-Based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy. CHE
18  2014 Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization. CHE, HCV
19  2014 Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. HE, MHE, PHES
20  2014 Useful tests for hepatic encephalopathy in clinical practice. CHE, HE
21  2013 Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis. HE, MHE
22  2012 Covert hepatic encephalopathy: not as minimal as you might think. HE, MHE
23  2012 Inhibitory control test for the detection of minimal hepatic encephalopathy in patients with cirrhosis of liver. ICT, MHE, PHES
24  2012 The effect of hepatic encephalopathy, hepatic failure, and portosystemic shunt on brain volume of cirrhotic patients: a voxel-based morphometry study. GM, HE, MHE, nHE, PS, TIPS, VBM, WM
25  2010 Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. HE, ICT